￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of whether gosatuzumab (Todavi) is a purely targeted drug

2026-02-01 22:25:32

Check Details
Treatment regimen and effect analysis of amivantamab combined with lazetinib

2026-02-01 22:25:32

Check Details
Which company develops and produces margetuximab?

2026-02-01 22:25:32

Check Details
Introduction to relevant information on Dacomitinib (Dacomitinib) Tablets obtaining the drug registration certificate

2026-02-01 22:25:32

Check Details
Brigatinib (Brigatinib) Takeda brand price and introduction to regular purchase channels

2026-02-01 22:25:32

Check Details
Common side effects of Entrectinib and how to effectively deal with them

2026-02-01 22:25:32

Check Details
Whether acalatinib has been officially included in the medical insurance catalog and its explanation

2026-02-01 22:25:32

Check Details
Instructions on whether ibrutinib (ibrutinib) must be continued for a long time after taking it

2026-02-01 22:25:32

Check Details
Detailed analysis of the functions and efficacy of ruxolitinib tablets (JAKAVI) and user feedback

2026-02-01 22:25:32

Check Details
Detailed explanation of the correct method of taking Clofazimine and guidance on treatment courses

2026-02-01 22:25:32

Check Details
Are the side effects of gosatuzumab (Todavi) serious and how to deal with them?

2026-02-01 22:25:32

Check Details
Detailed instructions for usage and dosage standards and adjustment plans of amivantamab

2026-02-01 22:25:32

Check Details
Category
相关知识